These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9599251)
21. Total syntheses of (+)- and (-)-cacospongionolide B, cacospongionolide e, and related analogues. Preliminary study of structural features required for phospholipase a2 inhibition. Cheung AK; Murelli R; Snapper ML J Org Chem; 2004 Aug; 69(17):5712-9. PubMed ID: 15307744 [TBL] [Abstract][Full Text] [Related]
22. Differential effects of manoalide on secreted and intracellular phospholipases. Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628 [TBL] [Abstract][Full Text] [Related]
23. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2. Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196 [TBL] [Abstract][Full Text] [Related]
24. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities. Hope WC; Patel BJ; Bolin DR Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057 [TBL] [Abstract][Full Text] [Related]
25. Cobra venom phospholipase A2 inhibition by manoalide. A novel type of phospholipase inhibitor. Lombardo D; Dennis EA J Biol Chem; 1985 Jun; 260(12):7234-40. PubMed ID: 3997864 [TBL] [Abstract][Full Text] [Related]
26. Effects of petrosaspongiolide R on the surface topology of bee venom PLA(2): a limited proteolysis and mass spectrometry analysis. Monti MC; Riccio R; Casapullo A Bioorg Chem; 2009 Feb; 37(1):6-10. PubMed ID: 18945473 [TBL] [Abstract][Full Text] [Related]
27. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide. Jacobson PB; Marshall LA; Sung A; Jacobs RS Biochem Pharmacol; 1990 May; 39(10):1557-64. PubMed ID: 2337412 [TBL] [Abstract][Full Text] [Related]
28. Effect of a series of 1-alkyl ether lipids on inhibition of phospholipase A2 activity and PAF responses. Kohler C; Carroll M; Tarrant E; Torley L; Wissner A Inflammation; 1993 Jun; 17(3):245-61. PubMed ID: 8330926 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of venom phospholipases A2 by manoalide and manoalogue. Stoichiometry of incorporation. Reynolds LJ; Mihelich ED; Dennis EA J Biol Chem; 1991 Sep; 266(25):16512-7. PubMed ID: 1885583 [TBL] [Abstract][Full Text] [Related]
30. Role of various phospholipases A2 and inhibitors in the pathogenesis and prevention of pancreatic acinar cell necrosis: studies with isolated rat pancreatic acini. Mössner J; Wessig C; Ogami Y; Keim V Int J Pancreatol; 2000 Feb; 27(1):29-38. PubMed ID: 10811021 [TBL] [Abstract][Full Text] [Related]
31. Modulation of acute and chronic inflammatory processes by cacospongionolide B, a novel inhibitor of human synovial phospholipase A2. García Pastor P; De Rosa S; De Giulio A; Payá M; Alcaraz MJ Br J Pharmacol; 1999 Jan; 126(1):301-11. PubMed ID: 10051149 [TBL] [Abstract][Full Text] [Related]
32. Hyrtiazepine, an azepino-indole-type alkaloid from the Red Sea marine sponge Hyrtios erectus. Sauleau P; Martin MT; Dau ME; Youssef DT; Bourguet-Kondracki ML J Nat Prod; 2006 Dec; 69(12):1676-9. PubMed ID: 17190441 [TBL] [Abstract][Full Text] [Related]
33. Manoalide. Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; Payá M; Alcaraz MJ Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221 [TBL] [Abstract][Full Text] [Related]
34. Use of short-chain cyclopentano-phosphatidylcholines to probe the mode of activation of phospholipase A2 from bovine pancreas and bee venom. Lin G; Noel J; Loffredo W; Stable HZ; Tsai MD J Biol Chem; 1988 Sep; 263(26):13208-14. PubMed ID: 3417654 [TBL] [Abstract][Full Text] [Related]